SCHEMBL30967628

SCHEMBL30967628

CC(C)(C)OC(=O)NCCN(CCO)C(=O)c1cc2c(Cl)nccc2[nH]1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CKS1B P61024 1/20 0.37
▸ SKP1 P63208 1/20 0.37
▸ SKP2 Q13309 1/20 0.37
▸ ATR Q13535 1/20 0.36
▸ BCHE P06276 1/20 0.36
▸ SSTR4 P31391 1/20 0.35
▸ HRH4 Q9H3N8 1/20 0.34
▸ PARP1 P09874 1/20 0.34
▸ ROCK2 O75116 1/20 0.34
▸ ROCK1 Q13464 1/20 0.34
▸ STK17B O94768 1/20 0.34
▸ STK17A Q9UEE5 1/20 0.34
▸ PYGL P06737 3/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ DYRK1A Q13627 1/20 0.33
▸ CCNC P24863 1/20 0.33
▸ CDK8 P49336 1/20 0.33
▸ SUV39H2 Q9H5I1 2/20 0.33
▸ ANO1 Q5XXA6 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30967451 0.86 PARP1 (0.36) CKS1BSKP1SKP2BCHESSTR4
SCHEMBL31751652 0.76 SMN1; SMN2 (0.44) ATRBCHEPARP1KDM4EPOLB
SCHEMBL30967478 0.68 CYP1A2 (0.44) ATRDYRK1AKDM4E
SCHEMBL20500778 0.66 TDP1 (0.54) CKS1BSKP1SKP2TDP1IDO1
SCHEMBL6753294 0.66 TDP1 (0.54) CKS1BSKP1SKP2SSTR4STK17B
SCHEMBL6988118 0.66 TACR1 (0.51) CKS1BSKP1SKP2
SCHEMBL24112892 0.65 NUDT1 (0.52) ROCK2ROCK1CCNCCDK8KDM4E
SCHEMBL25758891 0.65 ALOX15 (0.54) ROCK2ROCK1DYRK1ACCNCCDK8
SCHEMBL30189256 0.65 GRIN1 (0.50) CCNCCDK8KDM4E
SCHEMBL24113095 0.65 GRIN1 (0.50) CCNCCDK8KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4615838-A1 SUBSTITUTED BI-AND TRICYCLIC HSET INHIBITORS Merck Patent GmbH (DE) 2025-09-17 — — EP disclosed
WO-2024099898-A1 SUBSTITUTED BI-AND TRICYCLIC HSET INHIBITORS MERCK PATENT GMBH (DE) 2024-05-16 — — WO disclosed
Send feedback